English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

www.jogh.org • doi: 10.7189/jogh.10.020385 1 December 2020 • Vol. 10 No. 2 • 020385 Cervical cancer (CC) is largely preventable, however, while some high-income countries are nearing elimination status, it remains the leading cause of cancer-related death among women in many lowand middle-income countries (LMIC) [1]. Simms et al showed that with widespread coverage of both HPV vaccination and effective cervical screening by 2020, between 12.5 to 13.4 million cases of CC could be averted by 2070 [2]. This would, in turn, reduce CC incidence to less than four cases per 100 000, and effectively “eliminate” this disease by the end of the century, irrespective of development indices. Today, 85% of women diagnosed with cervical cancer live in LMIC [3] and the striking differences in access to vaccines, screening tests, diagnostic equipment and treatment between highand low-income countries cannot be ignored. Though not the sole requirement for effective implementation of cancer prevention programs, without these, urgent scale-up required to achieve elimination in some countries will not be feasible.

Strengthening global commitment to eliminating cervical cancer: What lessons from the past can we apply to the future?